tcsc0033469 BMS-813160

Order Now

AVAILABLE SIZES

$200.00 ORDERING INFORMATION International
TAICLONE BIOTECH CORP.
order@taiclone.com
+886-2-2735-9682
+886-2-2735-9807

Data sheet

Download PDF Datasheet

Technical Inquries

Submit Review

Product Description

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.

IC50 & Target: CCR2/CCR5[1]

Information

CAS No1286279-29-5
FormulaC25H40N8O2
Clinical Informationclinicalinformation
PathwayImmunology/Inflammation
GPCR/G Protein
TargetCCR
CCR

Specifications

Purity / Grade>98%
SolubilityDMSO : 25 mg/mL (51.58 mM; Need ultrasonic and warming)
Smilessmiles

Misc Information

Observed Molecular Weight484.64
Get valuable resources and offers directly to your email.